Volume | 1 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Sarepta Therapeutics Inc New | SRPT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
116.83 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
1 | 1 | - | 55.25 - 146.68 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
06:33:13 | 1 | US$ 117.83 | USD |
Sarepta Therapeutics (SRPT) Options Flow Summary
Sarepta Therapeutics Inc New Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
10.97B | 93.86M | - | 1.24B | -535.98M | -5.71 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sarepta Therapeutics News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRPT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 121.48 | 125.89 | 116.50 | 121.69 | 1,192,011 | -4.65 | -3.83% |
1 Month | 130.11 | 131.025 | 109.91 | 124.56 | 2,363,649 | -13.28 | -10.21% |
3 Months | 129.83 | 146.68 | 109.91 | 126.21 | 1,382,924 | -13.00 | -10.01% |
6 Months | 93.99 | 146.68 | 89.92 | 122.20 | 1,229,777 | 22.84 | 24.30% |
1 Year | 130.15 | 146.68 | 55.25 | 109.50 | 1,292,196 | -13.32 | -10.23% |
3 Years | 79.23 | 159.89 | 55.25 | 105.50 | 1,130,224 | 37.60 | 47.46% |
5 Years | 128.97 | 181.83 | 55.25 | 107.35 | 1,173,948 | -12.14 | -9.41% |
Sarepta Therapeutics Description
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development. |